申请人:Vitae Pharmaceuticals, Inc.
公开号:US20170081327A1
公开(公告)日:2017-03-23
Provided are novel compounds of Formula (I):
pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR
. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.